TLDR
There are four live spot XRP ETFs in the US, with a fifth from 21Shares (ticker TOXR) approved to list and pending launch. As of Dec 11, four are active per a market update, and Cboe has cleared 21Shares to list TOXR. Four active 21Shares approved
- Live issuers: Canary Capital, Bitwise, Grayscale, Franklin Templeton. Details
- Next in line: 21Shares TOXR on Cboe, 0.30% fee, awaiting final S-1 effectiveness. Exchange approval
- Context: XRP ETFs have seen steady net inflows, nearing $1 billion in a few weeks. Flows
Deep Dive
1. Live Issuers
As of mid December, four spot XRP ETFs are trading in the US from Canary Capital, Bitwise, Grayscale, and Franklin Templeton. A recent streak of daily inflows also names these issuers, underscoring active products and strong uptake. Issuer list and inflow streak
- This confirms the live count is four, not including pending products.
- The same update highlights robust daily subscriptions across the existing funds.
If you are tracking current availability, count four live products today across these managers.
2. Next In Line
21Shares has received Cboe BZX approval to list its spot XRP ETF under ticker TOXR, with a 0.30% sponsor fee and a multi-custodian setup; trading awaits final administrative steps on the registration side. Exchange approval and terms
- Coverage calls TOXR the likely fifth US spot XRP ETF once the final S-1 process is complete. Fifth ETF framing
- Reports note initial seeding and operational readiness once paperwork is finished.
Expect the live count to move from four to five when TOXR begins trading.
3. Flows And Market Context
XRP spot ETFs have recorded persistent net inflows and are approaching the $1 billion cumulative mark within weeks of launch, reflecting strong institutional demand. Flow estimate
- Multiple daily updates cite uninterrupted inflow streaks, which is unusual versus mixed flows in other crypto ETF segments. Inflow streak context
The pipeline is expanding alongside demand, so the product set could grow further if this momentum persists.
Conclusion
Now: four live US spot XRP ETFs, with 21Shares TOXR approved to list and poised to become the fifth upon final clearance. Strong, sustained inflows suggest ongoing interest, so the lineup may continue to expand as additional issuers clear final regulatory steps.
